Failure of ACAT inhibition to retard atherosclerosis

被引:30
作者
Fazio, S [1 ]
Linton, M [1 ]
机构
[1] Vanderbilt Univ, Med Ctr, Div Cardiovasc Med, Nashville, TN 37240 USA
关键词
D O I
10.1056/NEJMe068012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1307 / 1309
页数:3
相关论文
共 14 条
[11]   ACAT2 is a target for treatment of coronary heart disease associated with hypercholesterolemia [J].
Rudel, LL ;
Lee, RG ;
Parini, P .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (06) :1112-1118
[12]   Reduced ABCA1-mediated cholesterol efflux and accelerated atherosclerosis in apolipoprotein E-deficient mice lacking macrophage-derived ACAT1 [J].
Su, YR ;
Dove, DE ;
Major, AS ;
Hasty, AH ;
Boone, B ;
Linton, MF ;
Fazio, S .
CIRCULATION, 2005, 111 (18) :2373-2381
[13]   Effects of the acyl coenzyme A:: Cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions [J].
Tardif, JC ;
Grégoire, J ;
L'Allier, PL ;
Anderson, TJ ;
Bertrand, O ;
Reeves, F ;
Title, LM ;
Alfonso, F ;
Schampaert, E ;
Hassan, A ;
McLain, R ;
Pressler, ML ;
Ibrahim, R ;
Lespérance, J ;
Blue, J ;
Heinonen, T ;
Rodés-Cabau, J .
CIRCULATION, 2004, 110 (21) :3372-3377
[14]   CELL TOXICITY INDUCED BY INHIBITION OF ACYL-COENZYME A-CHOLESTEROL ACYLTRANSFERASE AND ACCUMULATION OF UNESTERIFIED CHOLESTEROL [J].
WARNER, GJ ;
STOUDT, G ;
BAMBERGER, M ;
JOHNSON, WJ ;
ROTHBLAT, GH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (11) :5772-5778